Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial).
Verry C, Dufort S, Villa J, Gavard M, Iriart C, Grand S, Charles J, Chovelon B, Cracowski JL, Quesada JL, Mendoza C, Sancey L, Lehmann A, Jover F, Giraud JY, Lux F, Crémillieux Y, McMahon S, Pauwels PJ, Cagney D, Berbeco R, Aizer A, Deutsch E, Loeffler M, Le Duc G, Tillement O, Balosso J.
Verry C, et al. Among authors: quesada jl.
Radiother Oncol. 2021 Jul;160:159-165. doi: 10.1016/j.radonc.2021.04.021. Epub 2021 May 5.
Radiother Oncol. 2021.
PMID: 33961915
Free article.
Clinical Trial.